CoChat

Gene therapy for the treatment of heart failure: promise postponed

Open access
Hulot, Jean-Sebastien, Ishikawa, Kiyotake, Hajjar, Roger J. · 2016 · European Heart Journal

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Gene therapy has emerged as a powerful tool in targeting the molecular mechanisms implicated in heart failure. Refinements in vector technology, including the development of recombinant adeno-associated vectors, have allowed for safe, long-term, and efficient gene transfer to the myocardium. These advancements, coupled with evolving delivery techniques, have placed gene therapy as a viable therapeutic option for patients with heart failure. However, after much promise in early-phase clinical trials, the more recent larger clinical trials have shown disappointing results, thus forcing the field to re-evaluate current vectors, delivery systems, targets, and endpoints. We provide here an updated review of current cardiac gene therapy programmes that have been or are being translated into clinical trials.

Overview

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehw019

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Cited by

See all 164

Metadata

Authors
Hulot, J.-S., Ishikawa, K., & Hajjar, R. J.
Affiliations
Icahn School of Medicine at Mount Sinai (US)
Corresponding author
Hajjar, Roger J.
Venue
European Heart Journal
Published
2016-02-27
Volume
37
Issue
21
Pages
1651-1658
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2290678689
Cited by
150
References
36
Citations by year
2026: 12 · 2025: 13 · 2024: 11 · 2023: 12 · 2022: 13 · 2021: 11 · 2020: 10 · 2019: 24 · 2018: 17 · 2017: 19 · 2016: 8
FWCI
3.03
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • European Heart Journal (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
National Institutes of Health (R01 HL117505, HL119046, HL128072, HL129814, P50 HL112324, T32HL007824, R01 HL113497)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
gene therapy, heart failure, adeno-associated virus vectors, clinical trials, translational research, cardiac vector, therapeutic target
MeSH terms
Animals, Calcium, Clinical Trials as Topic, Genetic Vectors, Heart Failure, Humans, Myocardial Contraction, Stem Cells, Calcium Channels, Genetic Therapy, Gene Transfer Techniques, Vascular Endothelial Growth Factor A, Angiogenesis Inducing Agents, Mice, Sarcoplasmic Reticulum Calcium-Transporting ATPases, Chemokine CXCL12

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene therapy for the treatment of heart failure: promise postponed. https://app.cochat.ai/papers/10.1093/eurheartj/ehw019
The paper
Hulot, J.-S., Ishikawa, K., & Hajjar, R. J. (2016). Gene therapy for the treatment of heart failure: promise postponed. European Heart Journal. https://doi.org/10.1093/eurheartj/ehw019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.